Cargando…

Investigating protein–excipient interactions of a multivalent V(HH) therapeutic protein using NMR spectroscopy

Multispecific therapeutic proteins come in a variety of formats, including bi- and tri-specific antibodies, dual-variable domain antibodies, and CrossMabs. These multivalent proteins are engineered to interact with multiple therapeutic target proteins with high specificity. Multi-domain proteins can...

Descripción completa

Detalles Bibliográficos
Autores principales: Panchal, Jainik, Falk, Bradley T., Antochshuk, Valentyn, McCoy, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519013/
https://www.ncbi.nlm.nih.gov/pubmed/36166705
http://dx.doi.org/10.1080/19420862.2022.2124902
_version_ 1784799310947287040
author Panchal, Jainik
Falk, Bradley T.
Antochshuk, Valentyn
McCoy, Mark A.
author_facet Panchal, Jainik
Falk, Bradley T.
Antochshuk, Valentyn
McCoy, Mark A.
author_sort Panchal, Jainik
collection PubMed
description Multispecific therapeutic proteins come in a variety of formats, including bi- and tri-specific antibodies, dual-variable domain antibodies, and CrossMabs. These multivalent proteins are engineered to interact with multiple therapeutic target proteins with high specificity. Multi-domain proteins can be created by linking together a variety of high-affinity antibody fragments. The choice of protein domains and linkers not only affects the interactions of these molecules with therapeutic targets but also influences the intrinsic behavior in solution that affects their stability. The complexity of solution interactions may translate into developability and manufacturing challenges. Here, we use nuclear magnetic resonance (NMR) spectroscopy to study the solution behavior of a multivalent V(HH) molecule composed of three flexibly linked heavy-chain-only domains that show dramatic stabilization against thermal degradation in the presence of sucrose. A collection of NMR fingerprinting and profiling methods were used to simultaneously monitor the protein solution behavior and capture details of protein–excipient interactions. We provide a framework to characterize and begin to understand the role of molecular flexibility in protein stabilization with potential applications in the design of novel therapeutic protein scaffolds that include multivalent proteins, fusion proteins, antibody-drug conjugates, and proteins modified with flexible lipids. ALPHABETICAL LIST OF ABBREVIATIONS: Fab Fragment antigen-binding; Fc Fragment crystallizable; HMW High molecular weight; ∆HMW Difference between HMW species at stress temperature and 5°C controls; IgG Immunoglobulin G; mAbs Monoclonal antibodies; MV-V(HH) Multivalent V(HH) molecule with the format aC-L(1)-aC-L(1)-aD; NMR Nuclear magnetic resonance; scFv Single-chain fragment variable; SEC Size-exclusion chromatography; V(HH) Variable domain of Heavy chain of Heavy chain-only antibody
format Online
Article
Text
id pubmed-9519013
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-95190132022-09-29 Investigating protein–excipient interactions of a multivalent V(HH) therapeutic protein using NMR spectroscopy Panchal, Jainik Falk, Bradley T. Antochshuk, Valentyn McCoy, Mark A. MAbs Report Multispecific therapeutic proteins come in a variety of formats, including bi- and tri-specific antibodies, dual-variable domain antibodies, and CrossMabs. These multivalent proteins are engineered to interact with multiple therapeutic target proteins with high specificity. Multi-domain proteins can be created by linking together a variety of high-affinity antibody fragments. The choice of protein domains and linkers not only affects the interactions of these molecules with therapeutic targets but also influences the intrinsic behavior in solution that affects their stability. The complexity of solution interactions may translate into developability and manufacturing challenges. Here, we use nuclear magnetic resonance (NMR) spectroscopy to study the solution behavior of a multivalent V(HH) molecule composed of three flexibly linked heavy-chain-only domains that show dramatic stabilization against thermal degradation in the presence of sucrose. A collection of NMR fingerprinting and profiling methods were used to simultaneously monitor the protein solution behavior and capture details of protein–excipient interactions. We provide a framework to characterize and begin to understand the role of molecular flexibility in protein stabilization with potential applications in the design of novel therapeutic protein scaffolds that include multivalent proteins, fusion proteins, antibody-drug conjugates, and proteins modified with flexible lipids. ALPHABETICAL LIST OF ABBREVIATIONS: Fab Fragment antigen-binding; Fc Fragment crystallizable; HMW High molecular weight; ∆HMW Difference between HMW species at stress temperature and 5°C controls; IgG Immunoglobulin G; mAbs Monoclonal antibodies; MV-V(HH) Multivalent V(HH) molecule with the format aC-L(1)-aC-L(1)-aD; NMR Nuclear magnetic resonance; scFv Single-chain fragment variable; SEC Size-exclusion chromatography; V(HH) Variable domain of Heavy chain of Heavy chain-only antibody Taylor & Francis 2022-09-27 /pmc/articles/PMC9519013/ /pubmed/36166705 http://dx.doi.org/10.1080/19420862.2022.2124902 Text en © 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Report
Panchal, Jainik
Falk, Bradley T.
Antochshuk, Valentyn
McCoy, Mark A.
Investigating protein–excipient interactions of a multivalent V(HH) therapeutic protein using NMR spectroscopy
title Investigating protein–excipient interactions of a multivalent V(HH) therapeutic protein using NMR spectroscopy
title_full Investigating protein–excipient interactions of a multivalent V(HH) therapeutic protein using NMR spectroscopy
title_fullStr Investigating protein–excipient interactions of a multivalent V(HH) therapeutic protein using NMR spectroscopy
title_full_unstemmed Investigating protein–excipient interactions of a multivalent V(HH) therapeutic protein using NMR spectroscopy
title_short Investigating protein–excipient interactions of a multivalent V(HH) therapeutic protein using NMR spectroscopy
title_sort investigating protein–excipient interactions of a multivalent v(hh) therapeutic protein using nmr spectroscopy
topic Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519013/
https://www.ncbi.nlm.nih.gov/pubmed/36166705
http://dx.doi.org/10.1080/19420862.2022.2124902
work_keys_str_mv AT panchaljainik investigatingproteinexcipientinteractionsofamultivalentvhhtherapeuticproteinusingnmrspectroscopy
AT falkbradleyt investigatingproteinexcipientinteractionsofamultivalentvhhtherapeuticproteinusingnmrspectroscopy
AT antochshukvalentyn investigatingproteinexcipientinteractionsofamultivalentvhhtherapeuticproteinusingnmrspectroscopy
AT mccoymarka investigatingproteinexcipientinteractionsofamultivalentvhhtherapeuticproteinusingnmrspectroscopy